Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
MRCP (UK), FRCP (Glasg.), MBBS
Internal Medicine Specialist
M.B.B.S, M.D (Internal Medicine)
Rheumatologist
MBBS, FCPS (Medicine), FCPS ( Rheumatology), CHPE , FRCP
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, MD (Internal Medicine), M.C.P.S
Gastroenterologist
MBBS, FMGEMS, FLEX, F.A.C.P, Diplomate of the American Board of Internal Medicine, Diplomate of the American Board of Gastroenterology
Gastroenterologist
MBBS, FMGEMS, FLEX, F.A.C.P, Diplomate of the American Board of Internal Medicine, Diplomate of the American Board of Gastroenterology
Internal Medicine Specialist
M.B.B.S. (KE), M.R.C.P (UK), M.D. (KE Medalist)
Internal Medicine Specialist
M.B.B.S. (KE), M.R.C.P (UK), M.D. (KE Medalist)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures